- Report
- June 2023
Serbia
From €1655EUR$1,850USD£1,455GBP
- Report
- June 2023
Saudi Arabia
From €1655EUR$1,850USD£1,455GBP
- Report
- June 2023
Hong Kong
From €1655EUR$1,850USD£1,455GBP
- Report
- November 2021
- 747 Pages
Global
From €3578EUR$4,000USD£3,146GBP
- Report
- November 2021
- 527 Pages
Global
From €3578EUR$4,000USD£3,146GBP
- Report
- November 2021
- 802 Pages
Global
From €4473EUR$5,000USD£3,933GBP
- Report
- November 2021
- 1165 Pages
Global
From €5368EUR$6,000USD£4,719GBP
The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies.
The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more